关于
  • English
  • About
    • Management
    • Board of Directors
    • Strategic Advisory Board
    • Our Partners
    • Proprietary Platform Technology
    • About TFChem
  • Programs
    • Pipeline
      • Antiviral
    • Skincare – Dark Spot Correction
    • Skincare – GlycoProteMim™
  • News
    • Sirona News
    • Events
  • Investors
    • Financial Information
    • Financial Reports
    • Investor & Media Kit
    • Newsletter
    • AGM
  • Contact
  • Careers

February 26th, 2019

Sirona Biochem Announces Financing

February 13th, 2019

Sirona Biochem Advances Skin Lightener TFC-1067 Development and IP Protection in Anticipation of Licensing Discussions

February 6th, 2019

Sirona Biochem Receives Up-front Payment for Right of First Refusal Contract for Skin Lightener TFC-1067

January 30th, 2019

Sirona Biochem Releases CEO Letter to Shareholders – Clinical trial results expected Q1 2019

December 11th, 2018

Sirona Biochem’s SGLT2 Inhibitor in Testing for Animal Health

  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 30
  • Next Page »

Archives

  • About
  • TFChem
  • Programs
  • News
  • Investors
  • Contact

© 2025 Sirona Biochem.

Sirona Biochem Corp
c/o WeWork
555 Burrard St.
Vancouver, B.C., Canada,V7X1M8

TFCHEM
Voie de l’innovation
Pharma Parc II Chaussée du Vexin
27100 Val de Reuil, France

Investor enquires: 604.641.4466
info@sironabiochem.com

© 2025 Sirona Biochem.

Sirona Biochem Corp
c/o WeWork
595 Burrard St.
Vancouver, B.C., Canada,V7X 1L4

TFCHEM
Voie de l’innovation
Pharma Parc II Chaussée du Vexin
27100 Val de Reuil, France

Investor enquires: 604.641.4466
info@sironabiochem.com

Enter your info below to subscribe to our newsletter:
Loading